Search
LivaNova PLC
LIVNAdd to Watchlist
71.740USD
+1.650+2.35%
Close 05/12, 16:00（ET）Quotes delayed by 15 min
3.92BMarket Cap
36.28P/E TTM
More Details of LivaNova PLC Company
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
LivaNova PLC Info
Ticker SymbolLIVN
Company nameLivaNova PLC
IPO dateOct 19, 2015
CEOMakatsaria (Vladimir A)
Number of employees2900
Security typeOrdinary Share
Fiscal year-endOct 19
Address20 Eastbourne Terrace
CityLONDON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited Kingdom
Postal codeW2 6LG
Phone442033250662
Websitehttps://www.livanova.com/
Ticker SymbolLIVN
IPO dateOct 19, 2015
CEOMakatsaria (Vladimir A)
Company Executives of LivaNova PLC
Name
Name/Position
Position
Shareholding
Change
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
--
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
--
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
6.80K
--
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
6.23K
--
Ahmet Tezel
Ahmet Tezel
Senior Vice President, Chief Innovation Officer
Senior Vice President, Chief Innovation Officer
4.16K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
739.57M
53.28%
Rest of World
379.30M
27.33%
Europe
269.18M
19.39%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.63%
PRIMECAP Management Company
7.69%
Millennium Management LLC
4.44%
Artisan Partners Limited Partnership
4.21%
AQR Capital Management, LLC
3.92%
Other
68.10%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.63%
PRIMECAP Management Company
7.69%
Millennium Management LLC
4.44%
Artisan Partners Limited Partnership
4.21%
AQR Capital Management, LLC
3.92%
Other
68.10%
Shareholder Types
Shareholders
Proportion
Investment Advisor
52.81%
Investment Advisor/Hedge Fund
32.62%
Hedge Fund
13.88%
Research Firm
2.81%
Pension Fund
2.25%
Bank and Trust
1.55%
Individual Investor
0.37%
Sovereign Wealth Fund
0.05%
Family Office
0.04%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
609
60.49M
110.12%
-11.26M
2025Q4
575
58.07M
106.34%
-10.58M
2025Q3
562
56.86M
104.13%
-8.50M
2025Q2
564
56.85M
104.11%
-6.95M
2025Q1
581
56.61M
103.82%
-8.04M
2024Q4
586
56.98M
104.84%
-8.56M
2024Q3
563
55.15M
101.56%
-9.48M
2024Q2
546
57.21M
105.64%
-8.52M
2024Q1
547
58.00M
107.51%
-6.90M
2023Q4
532
56.62M
105.11%
-7.28M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
6.39M
11.68%
+51.59K
+0.81%
Dec 31, 2025
PRIMECAP Management Company
4.22M
7.73%
-219.98K
-4.95%
Dec 31, 2025
Millennium Management LLC
3.48M
6.37%
+514.27K
+17.32%
Dec 31, 2025
Artisan Partners Limited Partnership
2.32M
4.23%
-111.72K
-4.60%
Dec 31, 2025
AQR Capital Management, LLC
2.16M
3.94%
+496.17K
+29.91%
Dec 31, 2025
Wellington Management Company, LLP
2.02M
3.69%
-328.86K
-14.02%
Dec 31, 2025
State Street Investment Management (US)
2.01M
3.68%
-43.95K
-2.14%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.79M
3.27%
+66.75K
+3.88%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.46M
2.67%
+12.75K
+0.88%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
1.66%
JPMorgan Active Small Cap Value ETF
1.43%
Invesco NASDAQ Future Gen 200 ETF
0.5%
Simplify Health Care ETF
0.43%
Global X Aging Population ETF
0.42%
JPMorgan Fundamental Data Science Small Core ETF
0.37%
Avantis US Small Cap Equity ETF
0.34%
iShares U.S. Medical Devices ETF
0.34%
WisdomTree US SmallCap Fund
0.33%
Federated Hermes MDT Small Cap Core ETF
0.33%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion1.66%
JPMorgan Active Small Cap Value ETF
Proportion1.43%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.5%
Simplify Health Care ETF
Proportion0.43%
Global X Aging Population ETF
Proportion0.42%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.37%
Avantis US Small Cap Equity ETF
Proportion0.34%
iShares U.S. Medical Devices ETF
Proportion0.34%
WisdomTree US SmallCap Fund
Proportion0.33%
Federated Hermes MDT Small Cap Core ETF
Proportion0.33%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
